Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents

John B. Fileta, Ingrid U. Scott, Harry W Flynn

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

BACKGROUND AND OBJECTIVE: To investigate the rate of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents, the spectrum of causative organisms, and associated visual acuity outcomes. PATIENTS AND METHODS: PubMed articles containing the keywords "endophthalmitis" and "intravitreal" between January 2005 and May 2012 were identified and reviewed. Inclusion criteria included article in English, more than 100 intravitreal anti-VEGF injections, and report of adverse events including endophthalmitis after intravitreal injection. RESULTS: Forty-three articles were analyzed. Endophthalmitis occurred after 197 of 350,535 intravitreal anti-VEGF injections (0.056%). The most common organisms isolated were coagulase-negative Staphylococcus (38.24%) and Streptococcus species (29.41%). CONCLUSION: The reported rate of endophthalmitis after intravitreal anti-VEGF injection is low. Coagulase-negative Staphylococcus and Streptococcus species were the most frequent causative organisms. Streptococcus species represent the causative organism of endophthalmitis after intravitreal VEGF injections at a higher rate than rates reported in the literature for endophthalmitis following most incisional intraocular surgeries. Among patients with endophthalmitis after intravitreal anti-VEGF injection, endophthalmitis caused by Streptococcus species is associated with poorer visual acuity outcomes than endophthalmitis caused by coagulase-negative Staphylococcus and culture-negative cases.

Original languageEnglish
Pages (from-to)143-149
Number of pages7
JournalOphthalmic Surgery Lasers and Imaging Retina
Volume45
Issue number2
DOIs
StatePublished - Jan 1 2014

Fingerprint

Intravitreal Injections
Endophthalmitis
Vascular Endothelial Growth Factor A
Meta-Analysis
Streptococcus
Coagulase
Injections
Staphylococcus
Visual Acuity
PubMed

ASJC Scopus subject areas

  • Ophthalmology
  • Surgery
  • Medicine(all)

Cite this

Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. / Fileta, John B.; Scott, Ingrid U.; Flynn, Harry W.

In: Ophthalmic Surgery Lasers and Imaging Retina, Vol. 45, No. 2, 01.01.2014, p. 143-149.

Research output: Contribution to journalArticle

@article{0fd5e2e4bddf442996452e286ad7a290,
title = "Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents",
abstract = "BACKGROUND AND OBJECTIVE: To investigate the rate of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents, the spectrum of causative organisms, and associated visual acuity outcomes. PATIENTS AND METHODS: PubMed articles containing the keywords {"}endophthalmitis{"} and {"}intravitreal{"} between January 2005 and May 2012 were identified and reviewed. Inclusion criteria included article in English, more than 100 intravitreal anti-VEGF injections, and report of adverse events including endophthalmitis after intravitreal injection. RESULTS: Forty-three articles were analyzed. Endophthalmitis occurred after 197 of 350,535 intravitreal anti-VEGF injections (0.056{\%}). The most common organisms isolated were coagulase-negative Staphylococcus (38.24{\%}) and Streptococcus species (29.41{\%}). CONCLUSION: The reported rate of endophthalmitis after intravitreal anti-VEGF injection is low. Coagulase-negative Staphylococcus and Streptococcus species were the most frequent causative organisms. Streptococcus species represent the causative organism of endophthalmitis after intravitreal VEGF injections at a higher rate than rates reported in the literature for endophthalmitis following most incisional intraocular surgeries. Among patients with endophthalmitis after intravitreal anti-VEGF injection, endophthalmitis caused by Streptococcus species is associated with poorer visual acuity outcomes than endophthalmitis caused by coagulase-negative Staphylococcus and culture-negative cases.",
author = "Fileta, {John B.} and Scott, {Ingrid U.} and Flynn, {Harry W}",
year = "2014",
month = "1",
day = "1",
doi = "10.3928/23258160-20140306-08",
language = "English",
volume = "45",
pages = "143--149",
journal = "Ophthalmic Surgery Lasers and Imaging Retina",
issn = "2325-8160",
publisher = "Slack Incorporated",
number = "2",

}

TY - JOUR

T1 - Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents

AU - Fileta, John B.

AU - Scott, Ingrid U.

AU - Flynn, Harry W

PY - 2014/1/1

Y1 - 2014/1/1

N2 - BACKGROUND AND OBJECTIVE: To investigate the rate of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents, the spectrum of causative organisms, and associated visual acuity outcomes. PATIENTS AND METHODS: PubMed articles containing the keywords "endophthalmitis" and "intravitreal" between January 2005 and May 2012 were identified and reviewed. Inclusion criteria included article in English, more than 100 intravitreal anti-VEGF injections, and report of adverse events including endophthalmitis after intravitreal injection. RESULTS: Forty-three articles were analyzed. Endophthalmitis occurred after 197 of 350,535 intravitreal anti-VEGF injections (0.056%). The most common organisms isolated were coagulase-negative Staphylococcus (38.24%) and Streptococcus species (29.41%). CONCLUSION: The reported rate of endophthalmitis after intravitreal anti-VEGF injection is low. Coagulase-negative Staphylococcus and Streptococcus species were the most frequent causative organisms. Streptococcus species represent the causative organism of endophthalmitis after intravitreal VEGF injections at a higher rate than rates reported in the literature for endophthalmitis following most incisional intraocular surgeries. Among patients with endophthalmitis after intravitreal anti-VEGF injection, endophthalmitis caused by Streptococcus species is associated with poorer visual acuity outcomes than endophthalmitis caused by coagulase-negative Staphylococcus and culture-negative cases.

AB - BACKGROUND AND OBJECTIVE: To investigate the rate of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents, the spectrum of causative organisms, and associated visual acuity outcomes. PATIENTS AND METHODS: PubMed articles containing the keywords "endophthalmitis" and "intravitreal" between January 2005 and May 2012 were identified and reviewed. Inclusion criteria included article in English, more than 100 intravitreal anti-VEGF injections, and report of adverse events including endophthalmitis after intravitreal injection. RESULTS: Forty-three articles were analyzed. Endophthalmitis occurred after 197 of 350,535 intravitreal anti-VEGF injections (0.056%). The most common organisms isolated were coagulase-negative Staphylococcus (38.24%) and Streptococcus species (29.41%). CONCLUSION: The reported rate of endophthalmitis after intravitreal anti-VEGF injection is low. Coagulase-negative Staphylococcus and Streptococcus species were the most frequent causative organisms. Streptococcus species represent the causative organism of endophthalmitis after intravitreal VEGF injections at a higher rate than rates reported in the literature for endophthalmitis following most incisional intraocular surgeries. Among patients with endophthalmitis after intravitreal anti-VEGF injection, endophthalmitis caused by Streptococcus species is associated with poorer visual acuity outcomes than endophthalmitis caused by coagulase-negative Staphylococcus and culture-negative cases.

UR - http://www.scopus.com/inward/record.url?scp=84898631546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898631546&partnerID=8YFLogxK

U2 - 10.3928/23258160-20140306-08

DO - 10.3928/23258160-20140306-08

M3 - Article

C2 - 24635156

AN - SCOPUS:84898631546

VL - 45

SP - 143

EP - 149

JO - Ophthalmic Surgery Lasers and Imaging Retina

JF - Ophthalmic Surgery Lasers and Imaging Retina

SN - 2325-8160

IS - 2

ER -